Cargando…

Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii

Toxoplasmosis is a serious disease caused by Toxoplasma gondii, one of the most widespread parasites in the world. Lipid metabolism is important in the intracellular stage of T. gondii. Stearoyl-CoA desaturase (SCD), a key enzyme for the synthesis of unsaturated fatty acid is predicted to exist in T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Pan, Alaraj, Intisar Q. M., Dulayymi, Juma’a R. Al, Baird, Mark S., Liu, Jing, Liu, Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Parasitology and Tropical Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870972/ https://www.ncbi.nlm.nih.gov/pubmed/27180571 http://dx.doi.org/10.3347/kjp.2016.54.2.139

Ejemplares similares

Synthesis of a Di-Mycoloyl Tri-Arabinofuranosyl Glycerol Fragment of the Mycobacterial Cell Wall, Based on Synthetic Mycolic Acids
por: Ali, Omar T., et al.
Publicado: (2019)

SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1
por: Huang, Wenlin, et al.
Publicado: (2015)

The Apoptotic Role of Metacaspase in Toxoplasma gondii
por: Li, Muzi, et al.
Publicado: (2016)

1,4-Disubstituted Thiosemicarbazide Derivatives are Potent Inhibitors of Toxoplasma gondii Proliferation
por: Dzitko, Katarzyna, et al.
Publicado: (2014)

New synthetic lipid antigens for rapid serological diagnosis of tuberculosis
por: Jones, Alison, et al.
Publicado: (2017)

Toxoplasma gondii
por: Liesenfeld, Oliver
Publicado: (2009)

Manipulation of body fat composition with sterculic acid can inhibit mammary carcinomas in vivo.
por: Khoo, D. E., et al.
Publicado: (1991)

Synthetic Chondramide A Analogues Stabilize Filamentous Actin and Block Invasion by Toxoplasma gondii
por: Ma, Christopher I., et al.
Publicado: (2013)

The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis
por: ALQAISI, A. Q. I., et al.
Publicado: (2018)

Two small-molecule inhibitors of Toxoplasma gondii proliferation in vitro
por: Hua, Qian-qian, et al.
Publicado: (2023)

Sterculic Oil, a Natural SCD1 Inhibitor, Improves Glucose Tolerance in Obese ob/ob Mice
por: Ortinau, Laura C., et al.
Publicado: (2012)

Pretreatment of human retinal pigment epithelial cells with sterculic acid forestalls fenretinide-induced apoptosis
por: William, Samuel, et al.
Publicado: (2022)

The transcriptome of Toxoplasma gondii
por: Radke, Jay R, et al.
Publicado: (2005)

Toxoplasma gondii and Schizophrenia
por: Torrey, E. Fuller, et al.
Publicado: (2003)

Toxoplasma gondii, Brazil
por: Gomez-Marin, Jorge
Publicado: (2007)

Prenatal Toxoplasma gondii
por: Linn, Edward S.
Publicado: (2011)

A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents Toxoplasma gondii Transmission to Foetuses in Mouse
por: Débare, Héloïse, et al.
Publicado: (2021)

The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis – Corrigendum
por: ALQAISI, A. Q. I., et al.
Publicado: (2018)

Genome-Wide Transcriptomic Analysis Identifies Pathways Regulated by Sterculic Acid in Retinal Pigmented Epithelium Cells
por: Pariente, Ana, et al.
Publicado: (2020)

Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
por: Liu, Quan, et al.
Publicado: (2015)

Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box
por: Spalenka, Jérémy, et al.
Publicado: (2018)

Determination of Cyclopropenoid Fatty Acids in Ewe Milk Fat by GC-MS after Intravenous Administration of Sterculic Acid
por: Lolli, Veronica, et al.
Publicado: (2020)

Seroepidemiology of human Toxoplasma gondii infection in China
por: Xiao, Yue, et al.
Publicado: (2010)

Potent In Vitro and In Vivo Effects of Stachys lavandulifolia Methanolic Extract against Toxoplasma gondii Infection
por: Alanazi, Abdullah D., et al.
Publicado: (2023)

Functional characterization of a unique cytochrome P450 in Toxoplasma gondii
por: Zhang, Xiao, et al.
Publicado: (2017)

Toxoplasma gondii in Australian smallgoods
por: Momcilovic, Tatjana
Publicado: (2010)

Toxoplasma gondii in the Subarctic and Arctic
por: Prestrud, Kristin W, et al.
Publicado: (2010)

Drug Resistance in Toxoplasma gondii
por: Montazeri, Mahbobeh, et al.
Publicado: (2018)

Toxoplasma gondii in the Food Supply
por: Hussain, Malik A., et al.
Publicado: (2017)

Cell Death by Toxoplasma gondii
por: de Oliveira, Claudio Bruno Silva, et al.
Publicado: (2020)

Human immunity to Toxoplasma gondii
por: Fisch, Daniel, et al.
Publicado: (2019)

The pathogenicity and virulence of Toxoplasma gondii
por: Sanchez, Syrian G., et al.
Publicado: (2021)

A Nuclear Factor of High Mobility Group Box Protein in Toxoplasma gondii
por: Wang, Hui, et al.
Publicado: (2014)

Effects of different drugs and hormone treatment on Toxoplasma gondii glutathione S-transferase 2
por: Li, Shuang, et al.
Publicado: (2022)

Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases
por: Peláez, Rafael, et al.
Publicado: (2020)

Sterculic Acid Alters Adhesion Molecules Expression and Extracellular Matrix Compounds to Regulate Migration of Lung Cancer Cells
por: Peláez, Rafael, et al.
Publicado: (2021)

The determinants regulating Toxoplasma gondii bradyzoite development
por: Pan, Ming, et al.
Publicado: (2022)

Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor
por: Choi, Won Hyung, et al.
Publicado: (2018)

Fatal Toxoplasma gondii infection in the giant panda
por: Ma, Hongyu, et al.
Publicado: (2015)

Toxoplasma gondii tachyzoite-extract acts as a potent immunomodulator against allergic sensitization and airway inflammation
por: Drinić, Mirjana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d60j8luc0ra7nm81afcp0992th